INEOS Inovyn to buy UK's only EDC asset and remaining Runcorn stake
- INEOS Inovyn will acquire the remaining 50% shareholding in Runcorn MCP Limited plus the EDC production assets and employees from Vynova Runcorn Limited, which entered administration in 2025.
- The transaction is subject to legal and regulatory approvals and is expected to complete later this year.
- The deal fully integrates the chlor‑alkali and ethylene dichloride (EDC) value chain under INEOS Inovyn to strengthen the site's long‑term future and customer supply security.
- Runcorn supplies around 98% of the chlorine used in UK drinking water treatment, making the site strategically critical for public health and national infrastructure.
Deal overview
INEOS Inovyn has agreed to acquire the remaining 50% shareholding in Runcorn MCP Limited together with the assets and employees associated with ethylene dichloride (EDC) production at Runcorn from Vynova Runcorn Limited, following Vynova's entry into administration in 2025. The transaction remains subject to the completion of necessary legal and regulatory processes and is expected to complete later this year.
Integration and purpose
By bringing the chlor‑alkali and EDC businesses together, INEOS Inovyn will fully integrate the value chain at Runcorn. The company says the move will strengthen the long‑term future of the site, enhance security of supply for customers and safeguard continuity of strategically critical chlor‑alkali operations in the UK.
Strategic importance
Runcorn provides around 98% of the chlorine used in UK drinking water treatment, underlining the site's role in public health and national infrastructure. The acquisition is presented as supporting water treatment, food manufacturing and a range of industries including pharmaceuticals, healthcare and construction, and as contributing to the UK's strategic autonomy and resilience.
Source: INEOS
